ミシガン州における頭頸部扁平上皮癌の臨床試験
ミシガン州内の拠点で、頭頸部扁平上皮癌に関する36件の研究が参加者を募集しています。
ミシガン州内の都市
- Grand Rapids15件の研究
- Detroit15件の研究
- Ann Arbor12件の研究
- Farmington Hills5件の研究
- Lansing4件の研究
- Flint4件の研究
- Waterford4件の研究
- Canton3件の研究
- Livonia3件の研究
公式研究テキスト（英語）
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- START Midwest Cancer and Hematology Centers of W Michigan, Grand Rapids
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06465069FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
- University of Michigan (Site # 161), Ann Arbor
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06788990Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Exelixis Clinical Site #65, Detroit
- Exelixis Clinical Site #13, Detroit
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/01更新 · NCT05176483177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
- BAMF Health, Grand Rapids
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/10/01更新 · NCT07189871Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton
- Trinity Health IHA Medical Group Hematology Oncology - Canton, Canton
- 他8件
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/01更新 · NCT06589804A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
- ALX Center 8, Farmington Hills
- ALX Center 3, Grand Rapids
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07085091A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
- Trinity Health St Joseph Mercy Ann Arbor, Ann Arbor
- Karmanos Cancer Institute, Detroit
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT07276399A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer
- University of Michigan Rogel Cancer Center, Ann Arbor
- Karmanos Cancer Institute, Detroit
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06385080BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- University of Michigan Rogel Cancer Center, Ann Arbor
- Bronson Battle Creek, Battle Creek
- 他23件
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/25更新 · NCT05136196Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
- START Midwest, Grand Rapids
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/18更新 · NCT05267626ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- Cancer & Hematology Centers of Western Michigan, Grand Rapids
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/14更新 · NCT05059444Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
- MyMichigan Medical Center Gratiot, Alma
- MyMichigan Medical Center Alpena, Alpena
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- 他60件
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/14更新 · NCT02734537A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
- Henry Ford, Detriot
- Karmanos Cancer Institute, Detroit
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/03更新 · NCT06163534A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
- Henry Ford Cancer Institute/Henry Ford Health System, Detroit
被験者募集中第2相
18歳以上 · 全性別 · 2026/08/21更新 · NCT06769698A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
- Research Site, Grand Rapids
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/19更新 · NCT07115043A Study to Assess the Adverse Events, Change in Disease Activity, and How Oral ABBV-711 Tablets Move Through the Body as a Monotherapy and in Combination With Intravenously Infused Budigalimab (ABBV-181), in Adults With Advanced Squamous Tumors
- START Midwest /ID# 272505, Grand Rapids
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/19更新 · NCT07241039Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
- University of Michigan Rogel Cancer Center, Ann Arbor
- Wayne State University/Karmanos Cancer Institute, Detroit
- Henry Ford Hospital, Detroit
- 他3件
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/08/17更新 · NCT04333537Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
- McLaren Cancer Institute-Bay City, Bay City
- McLaren Cancer Institute-Clarkston, Clarkston
- Wayne State University/Karmanos Cancer Institute, Detroit
- 他8件
被験者募集中第2相
18歳以上 · 全性別 · 2026/08/17更新 · NCT06532279Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors
- START Midwest, Grand Rapids
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/13更新 · NCT05985655A Study of MGC026 in Participants With Advanced Solid Tumors
- START Midwest, Grand Rapids
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/11更新 · NCT06242470A Study of DM005 in Patients With Advanced Solid Tumors
- Henry Ford Cancer Institute, Detroit
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/07更新 · NCT06515990Personalized Neck Radiation Therapy Directed by Sentinel Lymph Node Biopsy for the Treatment of Oral Cavity Squamous Cell Carcinoma, PRECEDENT Trial
- University of Michigan Comprehensive Cancer Center, Ann Arbor
被験者募集中第2相
18歳以上 · 全性別 · 2026/07/31更新 · NCT07121595Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
- Henry Ford Cancer Institute, Detroit
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/29更新 · NCT04198766A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
- Karmanos Cancer Institute, Detroit
- Karmanos Cancer Institute, Farmington Hills
被験者募集中第1相
18歳以上 · 全性別 · 2026/07/22更新 · NCT05208762First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
- START Midwest, Grand Rapids
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/07更新 · NCT05768139Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
- START Midwest /ID# 248685, Grand Rapids
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/23更新 · NCT05005403A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
- Karmanos Cancer Institute, Detroit
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/18更新 · NCT07503808Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
- University of Michigan Comprehensive Cancer Center Michigan Medicine /ID# 252010, Ann Arbor
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/04更新 · NCT04777994A Study of DB-1310 in Advanced/Metastatic Solid Tumors
- Henry Ford Health System, Detroit
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/04/06更新 · NCT05785741Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
- START Midwest, Grand Rapids
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/02/18更新 · NCT07030257A Phase II Study for p16+ Oropharyngeal Cancer PerSonalized De-escalation Treatment at University of MIchigan (CuSToMIze)
- University of Michigan Rogel Cancer Center, Ann Arbor
被験者募集中第2相
18歳以上 · 全性別 · 2026/02/02更新 · NCT05894083A Study of MT-4561 in Patients With Various Advanced Solid Tumors
- START Midwest, Grand Rapids
被験者募集中第1/2相
18歳以上 · 全性別 · 2025/12/11更新 · NCT06943521A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
- Research Site 129, Detroit
被験者募集中第1/2相
18歳以上 · 全性別 · 2025/11/21更新 · NCT05914116A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
- University of Michigan, Ann Arbor
被験者募集中第1/2相
18歳以上 · 全性別 · 2025/11/04更新 · NCT05902988A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
- University of Michigan, Ann Arbor
被験者募集中第1/2相
18歳以上 · 全性別 · 2025/09/24更新 · NCT05941507A Beta-only IL-2 ImmunoTherapY Study
- Karmanos Cancer Institute, Detroit
被験者募集中第1/2相
18歳以上 · 全性別 · 2025/07/09更新 · NCT05086692ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。